These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

789 related articles for article (PubMed ID: 25619197)

  • 21. Acutely decompensated heart failure with preserved and reduced ejection fraction present with comparable haemodynamic congestion.
    Van Aelst LNL; Arrigo M; Placido R; Akiyama E; Girerd N; Zannad F; Manivet P; Rossignol P; Badoz M; Sadoune M; Launay JM; Gayat E; Lam CSP; Cohen-Solal A; Mebazaa A; Seronde MF
    Eur J Heart Fail; 2018 Apr; 20(4):738-747. PubMed ID: 29251818
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biomarker Profiles in Heart Failure Patients With Preserved and Reduced Ejection Fraction.
    Tromp J; Khan MA; Klip IT; Meyer S; de Boer RA; Jaarsma T; Hillege H; van Veldhuisen DJ; van der Meer P; Voors AA
    J Am Heart Assoc; 2017 Mar; 6(4):. PubMed ID: 28360225
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insulin resistance in heart failure: differences between patients with reduced and preserved left ventricular ejection fraction.
    Scherbakov N; Bauer M; Sandek A; Szabó T; Töpper A; Jankowska EA; Springer J; von Haehling S; Anker SD; Lainscak M; Engeli S; Düngen HD; Doehner W
    Eur J Heart Fail; 2015 Oct; 17(10):1015-21. PubMed ID: 26198713
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HFpEF and HFrEF exhibit different phenotypes as assessed by leptin and adiponectin.
    Faxén UL; Hage C; Andreasson A; Donal E; Daubert JC; Linde C; Brismar K; Lund LH
    Int J Cardiol; 2017 Feb; 228():709-716. PubMed ID: 27886615
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterizing heart failure with preserved and reduced ejection fraction: An imaging and plasma biomarker approach.
    Kanagala P; Arnold JR; Singh A; Chan DCS; Cheng ASH; Khan JN; Gulsin GS; Yang J; Zhao L; Gupta P; Squire IB; Ng LL; McCann GP
    PLoS One; 2020; 15(4):e0232280. PubMed ID: 32349122
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heart Failure with Reduced Ejection Fraction (HFrEF) and Preserved Ejection Fraction (HFpEF): The Diagnostic Value of Circulating MicroRNAs.
    Chen YT; Wong LL; Liew OW; Richards AM
    Cells; 2019 Dec; 8(12):. PubMed ID: 31888288
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcomes in patients with heart failure with preserved, borderline, and reduced ejection fraction in the Medicare population.
    Cheng RK; Cox M; Neely ML; Heidenreich PA; Bhatt DL; Eapen ZJ; Hernandez AF; Butler J; Yancy CW; Fonarow GC
    Am Heart J; 2014 Nov; 168(5):721-30. PubMed ID: 25440801
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Can microRNAs emerge as biomarkers in distinguishing HFpEF versus HFrEF?
    Nair N; Gupta S; Collier IX; Gongora E; Vijayaraghavan K
    Int J Cardiol; 2014 Aug; 175(3):395-9. PubMed ID: 25002320
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of characteristics and outcomes of patients with heart failure preserved ejection fraction versus reduced left ventricular ejection fraction in an urban cohort.
    Quiroz R; Doros G; Shaw P; Liang CS; Gauthier DF; Sam F
    Am J Cardiol; 2014 Feb; 113(4):691-6. PubMed ID: 24484862
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Which heart failure patients profit from natriuretic peptide guided therapy? A meta-analysis from individual patient data of randomized trials.
    Brunner-La Rocca HP; Eurlings L; Richards AM; Januzzi JL; Pfisterer ME; Dahlström U; Pinto YM; Karlström P; Erntell H; Berger R; Persson H; O'Connor CM; Moertl D; Gaggin HK; Frampton CM; Nicholls MG; Troughton RW
    Eur J Heart Fail; 2015 Dec; 17(12):1252-61. PubMed ID: 26419999
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic value of N-terminal pro C-type natriuretic peptide in heart failure patients with preserved and reduced ejection fraction.
    Lok DJ; Klip IT; Voors AA; Lok SI; Bruggink-André de la Porte PW; Hillege HL; Jaarsma T; van Veldhuisen DJ; van der Meer P
    Eur J Heart Fail; 2014 Sep; 16(9):958-66. PubMed ID: 25082741
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heart failure with preserved ejection fraction has a better long-term prognosis than heart failure with reduced ejection fraction in old patients in a 5-year follow-up retrospective study.
    Kontogeorgos S; Thunström E; Johansson MC; Fu M
    Int J Cardiol; 2017 Apr; 232():86-92. PubMed ID: 28100428
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recovered heart failure with reduced ejection fraction and outcomes: a prospective study.
    Lupón J; Díez-López C; de Antonio M; Domingo M; Zamora E; Moliner P; González B; Santesmases J; Troya MI; Bayés-Genís A
    Eur J Heart Fail; 2017 Dec; 19(12):1615-1623. PubMed ID: 28387002
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic value of circulating microRNA-208a in differentiation of preserved from reduced ejection fraction heart failure.
    Li DM; Li BX; Yang LJ; Gao P; Ma ZY; Li ZJ
    Heart Lung; 2021; 50(1):71-74. PubMed ID: 32711895
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolomic fingerprint of heart failure with preserved ejection fraction.
    Zordoky BN; Sung MM; Ezekowitz J; Mandal R; Han B; Bjorndahl TC; Bouatra S; Anderson T; Oudit GY; Wishart DS; Dyck JR;
    PLoS One; 2015; 10(5):e0124844. PubMed ID: 26010610
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of elevated heart rate on clinical outcomes in patients with heart failure with reduced and preserved ejection fraction: a report from the CHART-2 Study.
    Takada T; Sakata Y; Miyata S; Takahashi J; Nochioka K; Miura M; Tadaki S; Shimokawa H;
    Eur J Heart Fail; 2014 Mar; 16(3):309-16. PubMed ID: 24464774
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Left atrial remodeling and function in advanced heart failure with preserved or reduced ejection fraction.
    Melenovsky V; Hwang SJ; Redfield MM; Zakeri R; Lin G; Borlaug BA
    Circ Heart Fail; 2015 Mar; 8(2):295-303. PubMed ID: 25593126
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of 5-Year Outcomes After Coronary Artery Bypass Grafting in Heart Failure Patients With Versus Without Preserved Left Ventricular Ejection Fraction (from the CREDO-Kyoto CABG Registry Cohort-2).
    Marui A; Nishiwaki N; Komiya T; Hanyu M; Tanaka S; Kimura T; Sakata R;
    Am J Cardiol; 2015 Aug; 116(4):580-6. PubMed ID: 26092271
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of Prognostic Usefulness of Serum Insulin-Like Growth Factor-Binding Protein 7 in Patients With Heart Failure and Preserved Versus Reduced Left Ventricular Ejection Fraction.
    Hage C; Bjerre M; Frystyk J; Gu HF; Brismar K; Donal E; Daubert JC; Linde C; Lund LH
    Am J Cardiol; 2018 Jun; 121(12):1558-1566. PubMed ID: 29622288
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pattern of endothelial progenitor cells and apoptotic endothelial cell-derived microparticles in chronic heart failure patients with preserved and reduced left ventricular ejection fraction.
    Berezin AE; Kremzer AA; Martovitskaya YV; Berezina TA; Gromenko EA
    EBioMedicine; 2016 Feb; 4():86-94. PubMed ID: 26981573
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.